BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 21963787)

  • 41. Celastrol ameliorates experimental colitis in IL-10 deficient mice via the up-regulation of autophagy.
    Zhao J; Sun Y; Shi P; Dong JN; Zuo LG; Wang HG; Gong JF; Li Y; Gu LL; Li N; Li JS; Zhu WM
    Int Immunopharmacol; 2015 May; 26(1):221-8. PubMed ID: 25858875
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Th1/Th17-mediated Immunity and Protection from Peripheral Neuropathy in Wildtype and IL10
    Brudvig JM; Cluett MM; Gensterblum-Miller EU; Chen J; Bell JA; Mansfield LS
    Comp Med; 2022 Apr; 72(2):63-77. PubMed ID: 35272743
    [No Abstract]   [Full Text] [Related]  

  • 43. Protection by mTOR Inhibition on Zymosan-Induced Systemic Inflammatory Response and Oxidative/Nitrosative Stress: Contribution of mTOR/MEK1/ERK1/2/IKKβ/IκB-α/NF-κB Signalling Pathway.
    Sahan-Firat S; Temiz-Resitoglu M; Guden DS; Kucukkavruk SP; Tunctan B; Sari AN; Kocak Z; Malik KU
    Inflammation; 2018 Feb; 41(1):276-298. PubMed ID: 29110153
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Effect of resveratrol on Treg/Th17 signaling and ulcerative colitis treatment in mice.
    Yao J; Wei C; Wang JY; Zhang R; Li YX; Wang LS
    World J Gastroenterol; 2015 Jun; 21(21):6572-81. PubMed ID: 26074695
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Delineation of the innate and adaptive T-cell immune outcome in the human host in response to Campylobacter jejuni infection.
    Edwards LA; Nistala K; Mills DC; Stephenson HN; Zilbauer M; Wren BW; Dorrell N; Lindley KJ; Wedderburn LR; Bajaj-Elliott M
    PLoS One; 2010 Nov; 5(11):e15398. PubMed ID: 21085698
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Peptidase PepP is a novel virulence factor of
    Heimesaat MM; Schmidt AM; Mousavi S; Escher U; Tegtmeyer N; Wessler S; Gadermaier G; Briza P; Hofreuter D; Bereswill S; Backert S
    Gut Microbes; 2020 Nov; 12(1):1770017. PubMed ID: 32584649
    [TBL] [Abstract][Full Text] [Related]  

  • 47. IFN-γ and IL-17A regulate intestinal crypt production of CXCL10 in the healthy and inflamed colon.
    Walrath T; Malizia RA; Zhu X; Sharp SP; D'Souza SS; Lopez-Soler R; Parr B; Kartchner B; Lee EC; Stain SC; Iwakura Y; O'Connor W
    Am J Physiol Gastrointest Liver Physiol; 2020 Mar; 318(3):G479-G489. PubMed ID: 31790273
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Gastroenteritis in NF-kappaB-deficient mice is produced with wild-type Camplyobacter jejuni but not with C. jejuni lacking cytolethal distending toxin despite persistent colonization with both strains.
    Fox JG; Rogers AB; Whary MT; Ge Z; Taylor NS; Xu S; Horwitz BH; Erdman SE
    Infect Immun; 2004 Feb; 72(2):1116-25. PubMed ID: 14742559
    [TBL] [Abstract][Full Text] [Related]  

  • 49. GPR120 Inhibits Colitis Through Regulation of CD4
    Yang W; Liu H; Xu L; Yu T; Zhao X; Yao S; Zhao Q; Barnes S; Cohn SM; Dann SM; Zhang H; Zuo X; Li Y; Cong Y
    Gastroenterology; 2022 Jan; 162(1):150-165. PubMed ID: 34536451
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Resveratrol inhibits inflammatory responses via the mammalian target of rapamycin signaling pathway in cultured LPS-stimulated microglial cells.
    Zhong LM; Zong Y; Sun L; Guo JZ; Zhang W; He Y; Song R; Wang WM; Xiao CJ; Lu D
    PLoS One; 2012; 7(2):e32195. PubMed ID: 22363816
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Mouse Models for Campylobacter jejuni Colonization and Infection.
    Stahl M; Graef FA; Vallance BA
    Methods Mol Biol; 2017; 1512():171-188. PubMed ID: 27885607
    [TBL] [Abstract][Full Text] [Related]  

  • 52. mTOR inhibitor INK128 attenuates dextran sodium sulfate-induced colitis by promotion of MDSCs on Treg cell expansion.
    Shi G; Li D; Ren J; Li X; Wang T; Dou H; Hou Y
    J Cell Physiol; 2019 Feb; 234(2):1618-1629. PubMed ID: 30132862
    [TBL] [Abstract][Full Text] [Related]  

  • 53. A Novel PAK1-Notch1 Axis Regulates Crypt Homeostasis in Intestinal Inflammation.
    Frick A; Khare V; Jimenez K; Dammann K; Lang M; Krnjic A; Gmainer C; Baumgartner M; Mesteri I; Gasche C
    Cell Mol Gastroenterol Hepatol; 2021; 11(3):892-907.e1. PubMed ID: 33189893
    [TBL] [Abstract][Full Text] [Related]  

  • 54. Boosting mTOR-dependent autophagy via upstream TLR4-MyD88-MAPK signalling and downstream NF-κB pathway quenches intestinal inflammation and oxidative stress injury.
    Zhou M; Xu W; Wang J; Yan J; Shi Y; Zhang C; Ge W; Wu J; Du P; Chen Y
    EBioMedicine; 2018 Sep; 35():345-360. PubMed ID: 30170968
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Clostridium difficile infection aggravates colitis in interleukin 10-deficient mice.
    Kim MN; Koh SJ; Kim JM; Im JP; Jung HC; Kim JS
    World J Gastroenterol; 2014 Dec; 20(45):17084-91. PubMed ID: 25493020
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Toll-like receptor 2 monoclonal antibody or/and Toll-like receptor 4 monoclonal antibody increase counts of Lactobacilli and Bifidobacteria in dextran sulfate sodium-induced colitis in mice.
    Dong L; Li J; Liu Y; Yue W; Luo X
    J Gastroenterol Hepatol; 2012 Jan; 27(1):110-9. PubMed ID: 21722182
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Dual-association of gnotobiotic IL-10-/- mice with 2 nonpathogenic commensal bacteria induces aggressive pancolitis.
    Kim SC; Tonkonogy SL; Karrasch T; Jobin C; Sartor RB
    Inflamm Bowel Dis; 2007 Dec; 13(12):1457-66. PubMed ID: 17763473
    [TBL] [Abstract][Full Text] [Related]  

  • 58. An antibiotic depleted microbiome drives severe Campylobacter jejuni-mediated Type 1/17 colitis, Type 2 autoimmunity and neurologic sequelae in a mouse model.
    Brooks PT; Bell JA; Bejcek CE; Malik A; Mansfield LS
    J Neuroimmunol; 2019 Dec; 337():577048. PubMed ID: 31678855
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Campylobacter jejuni-mediated induction of CC and CXC chemokines and chemokine receptors in human dendritic cells.
    Hu L; Bray MD; Geng Y; Kopecko DJ
    Infect Immun; 2012 Aug; 80(8):2929-39. PubMed ID: 22689814
    [TBL] [Abstract][Full Text] [Related]  

  • 60. The mTOR/NF-κB Pathway Mediates Neuroinflammation and Synaptic Plasticity in Diabetic Encephalopathy.
    Xu T; Liu J; Li XR; Yu Y; Luo X; Zheng X; Cheng Y; Yu PQ; Liu Y
    Mol Neurobiol; 2021 Aug; 58(8):3848-3862. PubMed ID: 33860440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.